Press "Enter" to skip to content

Coronavirus: Only around 1/3 of French respondents would take COVID-19 vaccine, Euronews poll shows

Just a bit over a third of French economists could have a low-cost COVID-19 vaccine, a Euronews-commissioned poll has shown.

France is one of the worst-hit nations in Europe in the disorder, with over 33,000 deaths as of October 16.

But only 37 percent of French people questioned would have a low-cost vaccine when it arrived available within the following calendar year.

This contrasts starkly to several of France’s neighbors, in which a majority say they’d get vaccinated.

Respondents from the United Kingdom have been keenest, using 63% financing vaccination, followed by Germany (57 percent ) and Italy (55 percent ).

There was also a comparison between the quartet as it came to examine their government’s handling of this COVID-19 crisis.

From the UK — the worst-hit nation in Europe about deaths — and France, the vast majority of respondents believed their authorities weren’t taking the ideal steps to correctly cover the crisis.

Germany’s government obtained the best opinions of these four, with 62% due to its management of this outbreak.

In Italy, 54 percent of respondents endorsed their government’s strategy.

What exactly does this mean for officials possibly considering a return to the sort of national lockdowns we saw from the spring?

A majority in the UK (58 percent ) and Germany (53 percent ) support a different lockdown, but the notion is popular with economists in France (38 percent ).

By important majorities, Germans and Italians do not think the European Union has a frequent approach to fight the virus. But just more than half the French do view that a unity of purpose among EU states. The problem does not appear in Britain because it is no longer a part of this bloc.

All in all, the optimism individuals experienced with the coming of the lifting of lockdown constraints seems to be evaporating amid the persistent daily signs of climbing cases and renewed stress on public health services.

Sample sizes of 1,500 were utilized in every nation.